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Although most  immunoglobulin classes are  represented on the  surface of 
thymus-independent (B) lymphocytes  1 and as secreted products, immunoglobu- 
lin D (IgD) is expressed principally as a cell-bound molecule (1, 2) and is found 
on the vast majority of splenic B cells in the adult mouse (3-5). 2 This unique 
status among immunoglobulin classes and the widespread distribution strongly 
suggest  that  surface IgD  (sIgD)  has  a  critical  role  in  B-cell  activation  or 
regulation. Such a role has yet to be demonstrated, however. In this paper we 
show that sIgD is important in the in vitro primary antibody response to the 
thymic-independent (T-I) antigen, trinitrophenyl-aminoethylcarbamylmethyl- 
Ficoll  (TNP-AECM-Ficoll). Thus,  an alloanti~  reagent inhibits the primary 
anti-TNP  response  to  TNP-AECM-Ficoll.  By  contrast,  this  reagent has  no 
detectable  effect on  the  anti-TNP  response  to  a  second T-I  antigen,  TNP- 
BruceUa abortus  (TNP-BA).  This result is particularly interesting as we have 
previously defined two  classes  of T-I  antigens,  differing in  their ability  to 
stimulate  B  cells  early  or  late  in  ontogeny  and  in  their  ability  to  cause 
antibody formation in the immune-defective CBA/N strain  (6). TNP-BA is a 
representative of T-I antigens which stimulate anti-TNP antibody formation 
by early neonatal and CBA/N spleen cells2 TNP-AECM-Ficoll fails to induce a 
response in CBA/N cells and cannot stimulate neonatal cells until 7-10 days 
after birth (6). The selective inhibitory activity of the anti~ reagent strongly 
suggests that sIgD plays a crucial role in the triggering of the class of B cells 
addressed by TNP-AECM-Ficoll, but is not essential to the response of B cells 
to TNP-BA. 
Materials and Methods 
Animals.  Mice of strains C57B1/Ka and BC8 were kindly provided by Dr. M. Potter (National 
Cancer Institute,  National Institutes of Health).  The BC8 strain is congenic with C57B1/Ka in 
1  Abbreviations  used  in  this paper:  B  lymphocytes,  thymus-independent  lymphocytes;  IgD, 
immunoglobulin D; pfc, plaque-forming cells; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide 
gel  electrophoresis;  sIgD,  surface  immunoglobulin  D;  T-I,  thymic-independent;  TNP-AECM- 
Ficoll, trinitrophenyl-aminoethylcarbamylmethyl-Ficoll; TNP-BA, trinitrophenyl-Brucella  abor- 
tus . 
2 The murine  immunoglobulin isotype referred to as IgD has not yet been formally demon- 
strated to be the analogue of human IgD. Consequently, it should be designated putative murine 
IgD. However, for simplicity, we will refer to it as IgD and to its heavy (H) chain as "8." 
J.  J.  Mond,  I.  Scher,  D.  E.  Mosier,  M.  Blaese,  and  W.  E.  Paul.  1977. T-independent 
responses in B-cell defective CBA/N mice to TNP-conjugates ofBrucella abortus  and to BruceUa 
abortus.  Manuscript submitted for publication. 
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that it bears the same "background" genes but possesses the Ig heavy chain markers of BALB/c, 
rather than those of C57B1/Ka. 
Culture System.  The method employed is a modification of that originally devised by Mishell 
and Dutton (7) and has been described (8).  Briefly, single cell suspensions of mouse spleen were 
cultured  in  flat-bottom  microtiter  plates  (IS-FB-96-TC;  Linbro  Chemical  Co.,  New  Haven, 
Conn.),  with  200-~1  cultures  containing  the  indicated  number  of cells  (106 unless  otherwise 
stated).  Cultures  were  incubated  at  37°C,  in  a  humidified  atmosphere  of  5%  CO2  in  air. 
Experimental  groups were  assayed  in triplicate.  Determination of numbers of plaque-forming 
cells (pfc) was carried out on the day of peak response  (day 3 or 4).  Anti-8 or control reagents 
were present throughout the entire culture period.  In some experiments,  irradiated cells were 
used as "fillers." They were irradiated (1,500 rads) in a  ~37Cs source (Isomedix Inc., Parsippany, 
N.J.) at a  dose-rate of 1,875 rads/min. 
Antigens.  TNP-AECM-Ficoll  was  prepared  as  described  by  Inman  (9).  The Ficoll  used  as 
starting material had an average molecular weight of 400,000 daltons; the molar ratio of TNP to 
Ficoll in the product was 56. 
TNP~BA was  prepared  as  described by  Mend  (see  footnote  3).  The  stock  suspension used 
contained approximately 108 microorganisms per milliliter. Dilutions of antigen expressed in this 
paper are dilutions of the stock; thus a 200-~1 microculture challenged with a  10  2 dilution would 
contain about 2  x  105 microorganisms. 
Plaque-Forming Cell Assay.  The method employed was a  modification for microscope slides 
of the haemolytic plaque assay of Jerne and Nordin (10).  TNP-sheep erythrocytes were prepared 
by the method of Rittenberg and Pratt (11).  Only data for direct (IgM) pfc are given. 
Numbers of pfc in individual culture wells were determined, and geometric mean and relative 
standard error for results from triplicate wells were calculated.  Data are expressed as pfc per 
culture or pfc per known number of cells. The antigen-specific pfc value (antigen-induced minus 
background) is the difference between the geometric means. The standard error of the geometric 
mean was transformed to an arithmetic scale by multiplying the geometric mean by the antilog 
of the standard error of the mean of the logarithmic values. The standard error of the differences 
of the geometric means was then calculated by a  conventional method (12). 
Cell Surface Iodination and Solubilization.  This procedure  was  performed as described by 
Kessler  (13).  50  x  106 nucleated spleen cells,  depleted of erythrocytes by hypotonic lysis,  were 
radiolabeled with 1 mCi 125I; the reaction was catalyzed by 1.5 IU lactoperoxidase  (grade B, 42 
IU/mg; Calbiochem, San Diego, Calif.). The washed cells were solubilized with 0.5% NP-40. This 
was followed by ultracentrifugation (110,000 g  for 30 min) and preabsorption with Staphylococcus 
aureus Cowan I strain (ATCC 12598).  50 ~1 of a  10% suspension (vol/vol) was used for the NP-40 
extract obtained from the equivalent of 25 ×  106 cells. The extract was incubated with S. aureus 
for 30 rain. 
lmmunoprecipitation.  This procedure  was  performed  as described  by  Cullen and Schwartz 
(14).  The rabbit anti-mouse-~ reagent used was kindly provided by Dr. Rose Mage (Laboratory 
of Immunology,  National  Institute  of Allergy  and  Infectious  Diseases,  National  Institutes of 
Health). Sequential precipitations were performed as described by Cullen et al.  (15). 
Sodium  Dodecyl  Sulfate-Polyacrylamide  Gel  Electrophoresis  (SDS-PAGE  Analysis).  The 
method used was a  modification (14) of that originally described by Laemmli (16).  All gels used 
for analysis contained 10% (wt/vol) acrylamide and all samples were reduced with 2-mercaptoeth- 
anol before analysis. 
Anti-8 and Control Reagents.  The reagents used were ascitic fluids generated in C57B1/Ka 
mice by the method of Tung et al.  (17).  To elicit the anti-8 reagent, C57B1/Ka mice received 107 
spleen cells from adult BALB/c donors intraperitoneally twice at weekly intervals. They were 
then rested for a  month and weekly injections of spleen cells resumed for 4 wk,  during which 
time the ascites were induced. To produce the control reagent, Hanks' balanced salt solution was 
substituted for the cell suspension in the immunization protocol; otherwise, timing of injections 
and  ascites  induction  were  identical.  Before  use,  either  for  immunoprecipitation  or  culture, 
reagents were deaggregated by ultracentrifugation (130,000 g  for 30 min in a  Beckman airfuge; 
Beckman Instruments, Inc., Cedar Grove, N.J.). 
The strain combination used here to produce alloanti~  (C57B1/Ka immunized with BALB/c), 
although different from that employed by Goding et al. (4; C57B1/6 anti-CBA), should nonetheless 
recognize  the  same  specificity,  because  IgD  from  both  BALB/c  and  CBA  bear  the  Ig  5.1 I.  M.  ZITRON~ D.  E.  MOSIER~ AND  W.  E.  PAUL  1709 
specificity,  which  is  lacking from  C57B1 IgD  (N.  L.  Warner,  personal  communication).  Our 
reagent will hereafter be referred to as anti-Ig 5.1. 
Ig Preparation  from  Ascitic Fluids.  Ig  was  precipitated  with  40%  saturated  ammonium 
sulphate.  Precipitated material was redissolved in phosphate-buffered  saline,  dialyzed exten- 
sively, and finally deaggregated by ultracentrifugation before use. 
Results 
Specificity  of the  Anti-Ig  5.1.  We  initially  wished  to  confirm that  the 
reagent generated by alloimmunization was,  in fact, specific  for the 8-heavy 
chain when tested on BC8 spleen cells. Inasmuch as no murine IgD plasmacy- 
tomas  have  been  reported,  we  have  analyzed reagents  by  their  ability  to 
precipitate iodinated spleen cell membrane components. Spleen cells from BC8 
and C57B1/Ka mice were iodinated, and extracts prepared for immunoprecipi- 
tation studies as described above. Gel profiles showing radioactivity precipitated 
by rabbit antimouse-K and putative anti-Ig 5.1 from such membrane prepara- 
tions are shown in Fig.  1.  Rabbit antimouse-K precipitates proteins with the 
mobility of/z- and 8-heavy chains using extracts from either strain  (Fig.  1 a 
and b). The light chain peak is indistinguishable from the running front using 
10% gels. The mobility of authentic/z-chain is indicated in the figures and was 
determined by the migration of fluoresceinated /z-chain used as an internal 
marker.  In  contrast  to  the  rabbit  antimouse  light  chain  antiserum,  the 
alloantibodies precipitated radioactive material from the BC8 membrane prep- 
aration (Fig. 1 c), but not from the C57B1/Ka (Fig. 1 d), demonstrating specificity 
for determinants encoded in the BALB/c allotype linkage group. The radioactive 
material precipitated from the solubilized BC8 membrane preparation did not 
comigrate with the /z-chain marker, but had the mobility of the non-/z peak 
precipitated by anti-K. This indicates that there is no detectable anti-/z activity 
in the anti-Ig 5.1. To confirm the identity of the non-/z material precipitated by 
anti-K and anti-Ig 5.1, sequential precipitations were performed as described in 
Materials and Methods.  Iodinated spleen cell extracts from BC8  mice were 
incubated in the first step with either rabbit  antimouse-K or normal rabbit 
serum, followed by precipitation of immune complexes with S.  aureus.  The 
rabbit anti-K precipitated the material usually seen with this reagent (data not 
shown, but identical to that in Fig. 1 a); no discrete peaks of radioactivity were 
precipitated by normal rabbit serum. The supernate from the first step was 
divided into four aliquots for the second precipitation; the reagents used were 
rabbit anti-K, normal rabbit serum, anti-Ig 5.1 and nonimmune ascites. Neither 
control reagent precipitated any radioactivity, nor did anti-K after anti-K. The 
gel  profiles  shown  in  Fig.  2  represent results  with  anti-Ig  5.1  after either 
normal rabbit  serum (Fig.  2 a)  or rabbit  antimouse-K preprecipitation (Fig. 
2 b).  The anti-K  removed the bulk of the material potentially precipitable by 
anti-Ig 5.1, whereas normal rabbit serum left this unaffected. 
Effect  of Anti-Ig  5.1  on  PFC  Responses  In  Vitro.  We  next  wished  to 
determine whether anti~ could inhibit in vitro antibody responses. We initially 
evaluated the effect of the continuous presence of anti-Ig 5.1  on the in vitro 
response  of BC8  cells,  which possess  the  5.1  allotypic determinant, and of 
congenic C57B1/Ka cells, which lack this determinant. BC8 or C57B1/Ka spleen 
cells (10  s) were cultured with a 1:50 dilution of anti-Ig 5.1, with a  h50 dilution 15,000 
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FIG.  1.  Analysis by SDS-PAGE of radioactivity precipitated from radioiodinated spleen 
cell extracts  from BC8  (panels a  and  c) and  C57B1/Ka  (panels b  and d) mice.  (a and b) 
Precipitation by rabbit antimouse-K  plus S.  aureus.  (c and d) Precipitation by anti-Ig 5.1 
and S. aureus,  tLm designates the internal  tL chain marker. 
of normal ascitic fluid or with no ascitic fluid in the presence or absence of 
TNP-AECM-Ficoll.  No  source  of exogenous  complement was  added.  Direct 
anti-TNP  pfc  were  measured  on  day  4.  As  shown  in  Table  I,  anti-Ig  5.1 
suppressed the response of BC8 spleen cells to TNP-AECM-Ficoll at all antigen 
concentrations tested, when compared either with cultures containing no ascitic 
fluid or  with nonimmune ascitic fluid.  Indeed,  nonimmune ascitic fluid ap- 
peared to somewhat enhance the antibody response to TNP-AECM-Ficoll and 
thus  the  effect of anti-Ig  5.1  is  even  more  dramatic  when  compared  with 
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Fro.  2.  Analysis by SDS-PAGE of radioactivity precipitated by anti-Ig 5.1 plus S. aureus 
from radioiodinated BC8 spleen cell extracts which had first been exposed to (a) normal 
rabbit serum plus S. aureus and (b) rabbit antimouse-K  antiserum plus S. aureus. 
TABLE  I 
The Effect of  Anti-Ig 5.1 Antibodies on the In Vitro PFC Responses of Spleen Cells from 
Congenic Mice Bearing Different Allotypic Determinants 
Direct anti-TNP pfc/10  e input cells* 
Additions to Culture 
No ascites  Nonimmune  ascites  Anti-lg 5.1 
(1:50)  (1:50) 
BC8 (Ig 5.1  +) 
TNP-AECM-Ficoll 
10  -2 ~g/ml  156.0 ±  1.3  323.8 ± 4.1  79.4 ±  20.4 
10  -a ~g/ml  185.1 ±  5.4  202.2 ±  14.7  50.7 ± 4.9 
10  -4/~g/ml  66.2 ± 2.5  129.8 ±  12.4  16.8 ±  1.3 
C57BL/Ka (Ig 5.1-) 
TNP-AECM-Ficoll 
10  -2 ~g/ml  143.4 ±  5.4  195.1 ±  18.9  273.7 -+ 8.5 
i0  -s ~g/ml  199.6 ±  23.7  292.7 ±  17.4 
10  -4 pg/ml  100.3 ±  20.5  169.4 ±  13.9 
* Calculation of antigen-specific  pfc/10  e cells  and standard error as described in Materials and 
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TABLE  II 
Effect on Nonimmune and Anti-Ig 5.1 Ascitic Fluids on the In Vitro PFC Responses of 
BC8 Spleen Cells to T-I Antigens 
Direct anti-TNP pfc/106 input cells* 
Additions to culture 
None  Nonimmune ascites  Anti-Ig 5.1 ascites 
Antigen 
TNP-AECM-Ficoll 
10  -2 ~g/ml  147.6 ± 11.6  (1:50)$ 216.3  ±  17.7  (1:50) 19.3 ± 1.2 
(1:100) 146.2  ±  14.1  (1:100) 97.4 ± 6.7 
10  -3 ~g/ml  165.8 -+ 3.0  (1:50) 111.7  ±  9.8  (1:50) 20.7 ± 3.2 
(1:100) 156.4  ±  3.4  (1:100) 24.4 ± 2.9 
10  -4 ~g/ml  9.5 -+ 5.3  (1:50) 24.5  _+  6.1  (1:50) 2.8 ± 0.5 
(1:100) 24.3  ±  3.3  (1:100) 1.6 -+ 1.7 
TNP-BA 
5 × 10  -~ dilution  148.1 ± 4.6  (1:50) 191.8 -+  15.7  (1:50) 175.3 ± 3.1 
(1:100) 224.6 ±  11.9  (1:100) 171.3 +- 7.4 
* Calculation of antigen-specific pfc/10  ~ cells and standard  error  as described in Materials  and 
Methods. 
$ Dilutions are given in parentheses. 
inhibitory effect on the response of C57B1/Ka cells to TNP-AECM-Ficoll. This 
establishes  that  the  blocking  effect  is  a  function  of the  interaction  of the 
immune ascitic fluid with a  product of the IgH chain region, presumably IgD. 
Because  TNP-BA can  stimulate  responses  by cell  populations  that  cannot 
respond to TNP-AECM-Ficoll, we then tested the effect of anti-Ig 5.1 upon the 
response of BC8 spleen cells to this antigen and obtained a  strikingly different 
result.  Anti-Ig 5.1 at 1:50 or 1:100 dilutions failed to inhibit the response of 10  ~ 
BC8 spleen cells to a  5  ×  10 -~ dilution of TNP-BA, although the same dilutions 
of anti-Ig  5.1  inhibited  responses  to  TNP-AECM-Ficoll at  all  antigen  doses 
tested (Table II). 
Although the results above clearly show differential effects of anti~ reagents 
on the in vitro antibody responses to TNP-BA and TNP-AECM-Ficoll, a  rela- 
tively trivial explanation was available which was derived from a  study of pre- 
cursor frequency for both antigens.  In normal adult spleen cells, TNP-BA acti- 
vates  roughly  fivefold  more  precursors  than  does  TNP-AECM-Ficoll  (D.  E. 
Mosier,  unpublished  observation).  Consequently, the usual culture conditions 
might provide only a slight excess of  precursors for TNP-AECM-Ficoll but a very 
substantial  excess of precursors for TNP-BA (i.e.,  the response is already at a 
level at which increasing the cell number fails to increase the pfc response). If 
the  anti-Ig 5.1  antibodies were  blocking only a  fraction of B  cells  in  culture, 
their effect would be more readily manifest on the TNP-AECM-Ficoll response. 
To rule out this possibility, the cell dilution experiments described below were 
performed, data from which are shown in Figs.  3 and 4.  In these experiments, 
only the number of responding cells were varied, whereas the antigen concen- 
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FIG.  3.  Cell  dilution curve for  BC8 spleen  cells  responding to TNP-AECM-Ficoll  (10 -z 
/~g/ml) in the presence of nonimmune (O) or anti-Ig 5.1  (A) immunoglobulin. 
culture were held constant.  Constant total cell density was achieved by using 
BC8 spleen cells exposed to 1,500 rads as nonresponding '~filler" cells.  Instead of 
using  the  ascitic  fluids  in  these  cultures,  Ig  prepared  from  ascitic  fluid,  as 
described in Materials and Methods, was used. The final concentration of Ig in 
culture was 50 izg/ml. 
The cell  dilution curve for the response to 10 -2  ~g/ml TNP-AECM-Ficoll  is 
shown in Fig.  3.  Data are plotted as antigen-specific  pfc per microwell against 
the  number  of  responding  cells.  The  anti-Ig  5.1  caused  greater  than  90% 
suppression  at  responding  cell  numbers  of 106  and  1.5  ×  106. With  2  ×  106 
responding  cells,  the  suppression  was  only  of the  order  of 40%.  These  data 
indicate that even in a response highly susceptible to suppression, the suppres- 
sion may be minimized by increasing the number of responding cells exposed to 
the reagent. The above data made it important to perform a similar experiment 
with TNP-BA as the antigen,  and these results are shown in Fig.  4. At no cell 
concentration was the TNP-BA response susceptible to anti-Ig 5.1 suppression. 100 
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FIG.  4.  Cell  dilution curve for BC8 spleen cells responding  to TNP-BA  (10 -2 dilution  of 
stock) in the presence of nonimmune  ($) or anti-Ig 5.1  (A) immunoglobulin. 
A  final  series  of  experiments  were  performed  to  examine  the  effect  of 
challenge  antigen  concentration  on the  suppression  by anti-Ig  5.1.  This was 
tested by assaying the day 4 responses of l0  s BC8 spleen cells in the presence of 
either  anti-Ig  5.1 or control  ascites  (at  a  1:50 dilution)  over a  wide range  of 
concentration  of each  antigen.  The  data  are  shown  in  Figs.  5 a  (response to 
TNP-AECM-Ficoll) and 5 b (response to TNP-BA). The suppression of the TNP- 
AECM-Ficoll response is consistent over the  antigen  dose range  10°-10  -" /~g/ 
ml.  The  dose-response curves for TNP-BA in the  presence of anti-Ig  5.1  and 
nonimmune  ascites are identical over the range of antigen dilutions 10-L10-s; 
at the 10  -e dilution there is a  small but significant response in the presence of 
nonimmune ascites, which was eliminated by anti-Ig 5.1. 
Discussion 
The results presented here show that the in vitro anti-TNP response to one 
T-I antigen,  TNP-AECM-Ficoll, is inhibited by anti-Ig 5.1 antibodies, whereas 1715 
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FIG.  5.  Effect of anti-Ig 5.1 (©) or nonimmune (O) ascites on the in vitro pfc responses of 
BC8 spleen cells (10  s) using wide ranges of antigen concentrations. (a) Responses to TNP- 
AECM-Ficoll. (b) Responses to TNP-BA. 
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that to a second T-I antigen, TNP-BA is resistant to this inhibition.  In fact, our 
data demonstrate that the response to TNP-AECM-Ficoll is suppressed at all 
antigen  doses tested and  all cell numbers  employed,  although  the  inhibition 
when  2  x  106  cells  are  used  is  less  striking.  The  relative  insensitivity  to 
inhibition  of cultures with high cell numbers presumably reflects a  relatively 
low titer of anti-Ig 5.1  in the  inhibiting  reagent.  The response to TNP-BA is 
not inhibited  at any cell concentration  tested nor at any antigen  dose except 
the lowest (10 -6 dilution).  Indeed,  when TNP-BA is used at 10  -s dilution,  the 
response observed is quite small and neither neonatal mice nor mice with the 
X-linked  CBA/N defect respond,  although  both respond  quite well to higher 
concentrations of TNP-BA (see footnote 3). 
Two  alternative  explanations  may be  proposed to  explain  the  differential 
sensitivities of responses to TNP-AECM-Ficoll and to optimal concentrations of 
TNP-BA  to  anti-Ig  5.1.  The  first  is  that  the  two  antigens  address  distinct 
subpopulations of B  cells which differ in their expression of sIgD.  The second 
explanation  is that a  single population of cells is responsive to both antigens, 
but  that  TNP-AECM-Ficoll  and  TNP-BA  employ  different  mechanisms  to 
trigger cells to antibody production. 
The former explanation has support from several sets of observations. It has 
been  shown that  TNP-BA can  elicit good antibody responses  from splenic B 
cells of neonatal mice, whereas the response to TNP-AECM-Ficoll is marginal 
until the mice are 1 to 2 wk of age (6). Thus, the acquisition of responsiveness 
to TNP-AECM-Ficoll  is similar  in timing  to the  appearance  of sIgD because 
this  isotype  is  poorly  expressed  by  neonatal  B  cells  but  rises  in  relative 1716  ROLE  OF  sIgD  IN  B-CELL  RESPONSES 
amounts over the first 4 wk of life (18). Similarly, mice with the CBA/N X- 
linked B-lymphocyte defect respond to high concentrations of TNP-BA, but do 
not respond to TNP-AECM-Ficoll at any concentration. The B cells of adult 
defective mice  are  similar,  in  terms  of sIg  phenotype,  to  those  of young, 
nondefective animals, in that the ratio of sIgD to sIgM is only about one-third 
that found in nondefective adult spleen cell populations  (19). These findings 
support the existence of at least two subpopulations of B cells that differ in sIg 
phenotype. To further support the notion of a distinctive cell type responsive to 
each of the antigens, preliminary results indicate the complete susceptibility of 
the TNP-AECM-Ficoll response (in normal strains) to anti-Lyb 5 and comple- 
ment;  4 the TNP-BA response is only partially affected by this treatment. We 
would  suggest  further that  each  of these  two  antigens  may be  seen  as  a 
prototype of a class of T-I antigens, distinguished operationally by their ability 
to elicit antibody responses from neonatal, nondefective spleen cells and from 
CBA/N mice. In the group capable of eliciting such responses would be TNP- 
BA  and,  with  it,  TNP-derivatives of lipopolysaceharide and polyacrylamide 
beads. We refer to these as T-I 1 antigens (6). The group of antigens capable of 
stimulating only more mature cells  includes TNP-AECM-Ficoll  and  levan, 
dextran,  pneumococcal  polysaccharide,  and  polyinosinic:polycytidilic acid. 
These are designated T-I 2 antigens. 
As noted above, an alternative explanation for our data is that at least some 
of the response to TNP-BA in the nondefective adult is mediated by cells that 
can also respond to TNP-AECM-Ficoll. Inasmuch as only the response to TNP- 
AECM-Ficoll is anti-Ig 5.1  inhibitable,  this implies different mechanisms of 
triggering  the  same  cell  by  two  T-I  antigens  bearing  the  same  haptenic 
determinant. 
Our experiments do not address the question of the mechanism by which 
anti-Ig 5.1 inhibits the response to TNP-AECM-Ficoll. Essentially, three basic 
mechanisms may be envisaged. The first, and simplest, is that for the class of 
T-I antigens represented by TNP-AECM-Ficoll, effective induction involves a 
transmembrane "signal" which requires the participation of sIgD, sIgM alone 
being inadequate. Thus,  blocking the sIgD receptors with antibody prevents 
antigen binding and signal generation. The second possibility is that induction 
requires occupancy, by antigen, of a certain threshold fraction of the total sIg 
molecules.  Blocking of sIgD  might prevent the  binding  of antigen  to  this 
critical number of receptors. Both of these proposals imply that occupancy of 
sIgD receptors by antigen and by anti-Ig causes very different outcomes, the 
former leading to signal generation, the latter not. Finally, it is also possible 
that the suppression by anti-Ig 5.1 is active, rather than passive, and that the 
binding  of anti-Ig  5.1  to  sIgD  generates a  "negative signal"  leading to  an 
inhibited response. 
Our success in showing a role for sIgD was based upon the choice of TNP-BA 
and TNP-AECM-Ficoll as test antigens. The choice of these antigens was not 
fortuitous, but based upon our knowledge of the ontogeny of responsiveness to a 
range of T-I antigens and the development of splenic B cells with respect to sIg 
phenotype in normal mice (6). 
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Summary 
An alloanti4  antibody was prepared by immunizing C57BL/Ka mice with 
BALB/c spleen cells. Its specificity for 8-chain was demonstrated by immunopre- 
cipitation and SDS-PAGE of 125I-labeled membrane proteins from BC8 spleen 
cells. BC8 mice possess C57BL/Ka "background" genes and BALB/c IgH genes. 
The anti4  reagent without complement inhibited the primary in vitro anti- 
TNP antibody response to TNP-AECM-Ficoll by BC8 spleen cells, although it 
had no effect on the  anti-TNP response  of congenic C57BL/Ka spleen cells, 
which lack the 8-allotype identified by this antibody. On the other hand, the 
anti~ antibody had no effect on the anti-TNP response of BC8 spleen cells to 
TNP-BA,  except at limiting antigen concentrations.  Both TNP-AECM-Ficoll 
and TNP-BA are T-I antigens, but they differ in that TNP-AECM-Ficoll fails 
to  stimulate  in  vitro  responses  by  immunologically defective  CBA/N  and 
neonatal spleen cells whereas TNP-BA can cause responses from both these 
animals. These results suggest that the IgD receptor is critical to T-I antibody 
responses  initiated by TNP-AECM-Ficoll but  that  it  is  not required for T-I 
responses stimulated by TNP-BA. 
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